Medicare Enrolled

Dr. Kenny Nall, MD

Pulmonary Disease · Washington, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
628 E 12TH ST, Washington, NC 27889
2529749361
In practice since 2005 (20 years)
NPI: 1710961727 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nall from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nall? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nall

Dr. Kenny Nall is a pulmonary disease specialist in Washington, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nall performed 1,214 Medicare services across 890 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nall received a total of $4,089 from 35 pharmaceutical and/or device companies across 170 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nall is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 28% volume in NC $4,089 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,214
Medicare services
Top 28% in NC for pulmonary disease
890
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~61 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
180 $92 $232
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
177 $15 $81
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
173 $20 $73
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
173 $20 $67
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
164 $61 $185
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
69 $135 $313
Inhaled albuterol and ipratropium bromide via DME
Administration of FDA-approved albuterol and ipratropium bromide medication through durable medical equipment.
50 $0 $6
Inhalation treatment for airway obstruction or sputum production
A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production.
44 $7 $32
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
42 $58 $178
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
34 $37 $96
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
27 $116 $357
Bronchial secretion aspiration via endoscope
Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus.
23 $133 $682
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
18 $12 $47
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
15 $92 $256
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
14 $89 $337
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
11 $135 $499
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,089
Total received (2018-2024)
Avg $682/year across 6 years
Top 36% in NC for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
170
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,089 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,668
2023
$1,719
2022
$219
2021
$155
2019
$156
2018
$173

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$620
GlaxoSmithKline, LLC.
$343
Boehringer Ingelheim Pharmaceuticals, Inc.
$147
Resmed Corp
$76
Philips North America LLC
$74
QOL Medical, LLC
$60
Regeneron Healthcare Solutions, Inc.
$46
Baxter Healthcare
$46
Merck Sharp & Dohme LLC
$45
GENZYME CORPORATION
$32
Intercept Pharmaceuticals, Inc.
$27
Tactile Systems Technology Inc
$24
Insmed, Inc.
$23
Inspire Medical Systems, Inc.
$22
Grifols USA, LLC
$19
VIVUS LLC
$18
Phathom Pharmaceuticals, Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
ABBVIE INC.
$14
Top 3 companies account for 66.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,271
GlaxoSmithKline, LLC.
$830
Boehringer Ingelheim Pharmaceuticals, Inc.
$479
Mylan Specialty L.P.
$230
Janssen Pharmaceuticals, Inc
$178
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$98
Baxter Healthcare
$90
Merck Sharp & Dohme LLC
$80
Resmed Corp
$76
Philips North America LLC
$74
QOL Medical, LLC
$60
ABBVIE INC.
$51
Mallinckrodt Hospital Products Inc.
$49
Regeneron Healthcare Solutions, Inc.
$46
Inspire Medical Systems, Inc.
$41
Grifols USA, LLC
$39
VIVUS LLC
$34
GENZYME CORPORATION
$32
Pharmacosmos Therapeutics Inc.
$30
Intercept Pharmaceuticals, Inc.
$27
Sunovion Pharmaceuticals Inc.
$25
Tactile Systems Technology Inc
$24
Nestle HealthCare Nutrition Inc.
$23
Insmed, Inc.
$23
ADVANCED RESPIRATORY, INC
$21
Allergan Inc.
$19
Merck Sharp & Dohme Corporation
$18
Circassia Pharmaceuticals Inc
$18
INTERCEPT PHARMACEUTICALS, INC.
$17
Phathom Pharmaceuticals, Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Novartis Pharmaceuticals Corporation
$14
PFIZER INC.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$13
E.R. Squibb & Sons, L.L.C.
$12
Top 3 companies account for 63.1% of all-time payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · AREXVY · AVYCAZ · Arikayce · BREZTRI · BROVANA · CHANTIX · DIFICID · DUPIXENT · ELIQUIS · ENTYVIO · FASENRA · Flexitouch Plus · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · LINZESS · LifeVest · MONOFERRIC · NIOX VERO · NUCALA · OCALIVA · OFEV · Prolastin-C Liquid · QSYMIA · STIOLTO RESPIMAT · SUCRAID · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · The Vest System Model 105 Home Care · VIBERZI · VOQUEZNA · XARELTO · XIFAXAN · XOLAIR · YUPELRI · Yupelri · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Washington?
Compare pulmonary diseases in the Washington area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
19
Per 100K population
42.6
County median income
$57,997
Nearest hospital
WASHINGTON COUNTY HOSP INC
18.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nall is a clinical cardiology specialist, with above-average Medicare volume (top 28% in NC), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nall experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Nall performed 180 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nall receive payments from pharmaceutical companies?
Yes. Dr. Nall received a total of $4,089 from 35 companies across 170 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nall's costs compare to other pulmonary diseases in Washington?
Dr. Nall's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nall) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →